BofA lowered the firm’s price target on Bristol Myers (BMY) to $58 from $63 and keeps a Neutral rating on the shares. For Q1, the firm’s total ...

Biotech giant Bristol-Myers Squibb Company BMY is scheduled to report first-quarter 2025 results on April 24, before market ...

The layoffs come as the biotech industry struggles. The post Mass. biotech company cuts 90% of workforce appeared first on Boston.com.

Bank of America trimmed Bristol Myers Squibb’s target price from $63 to $58 while sticking with its neutral rating. This reflects lowered revenue and EPS expectations for the company in both the near ...